# ctDNA for Early Detection of Recurrence in Melanoma

> **NCT06246227** · — · ACTIVE_NOT_RECRUITING · sponsor: **Herlev and Gentofte Hospital** · enrollment: 467 (actual)

## Conditions studied

- Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06246227
- **Lead sponsor:** Herlev and Gentofte Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-07-01
- **Primary completion:** 2027-10-06
- **Final completion:** 2028-01-01
- **Target enrollment:** 467 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06246227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06246227, "ctDNA for Early Detection of Recurrence in Melanoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06246227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*